| Bioactivity | (D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide (Compound 4) is a somatostatin analog with Kds of 0.61, 11.05, 23.5, 1200 and >1000 nM for SSTR5, SSTR3, SSTR2, SSTR1 and SSTR4, respectively[1]. |
| Target | Kd: 0.61 nM (SSTR5), 11.05 nM (SSTR3), 23.5 nM (SSTR2), 1200 nM (SSTR1), >1000 nM (SSTR4) |
| Name | (D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide |
| CAS | 340821-13-8 |
| Sequence | {d-Phe}-Cys-Phe-{d-Trp(N-Me)}-Lys-Thr-Cys-Thr-NH2 (Disulfide bridge: Cys2-Cys7) |
| Shortening | {d-Phe}-CF-{d-Trp(N-Me)}-KTCT-NH2 (Disulfide bridge: Cys2-Cys7) |
| Formula | C50H67N11O10S2 |
| Molar Mass | 1046.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nikiforovich GV, et al. Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors. Chem Biol Drug Des. 2007 Mar;69(3):163-9. |
(D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide
CAS: 340821-13-8 F: C50H67N11O10S2 W: 1046.26
(D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide (Compound 4) is a somatostatin analog with Kds of 0.61, 11.05,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.